DEXCOM INC (DXCM)
Clinical trial NCT04261738 updates: 1. status: SUSPENDED → TERMINATED 2. completion date: 2026-12-01 → 2025-09-04 3. primary completion date: 2026-12-01 → 2025-09-04 4. enrollment: 24 → 6 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical